Add BrightSurf on Google Email

Science News Archive 2009 - Page 252


Page 252 of 277

Model of pre-exposure prophylaxis against HIV forecasts benefits, potential cost-effectiveness

A new mathematical model predicts that pre-exposure prophylaxis (PrEP) could substantially reduce the lifetime risk of HIV infection, but its cost-effectiveness varies depending on target population and drug costs. With modest improvements, PrEP might be as effective as other public health interventions.

SourceNIH/National Institute of Allergy and Infectious Diseases·JournalClinical Infectious Diseases·DateFeb 9, 2009

First genome-wide expression analysis yields better understanding of how leukemia develops

A genome-wide expression analysis identified 3,005 differentially expressed genes, including a ribosome and T-cell receptor signaling pathway. The study provides critical insight into the differences between leukemic stem cells and normal blood stem cells, potentially leading to targeted therapies.

SourceUniversity of Rochester Medical Center·JournalProceedings of the National Academy of Sciences·DateFeb 9, 2009

Accidental wireless

A wireless Java-enabled system can automatically call emergency services after a rollover accident, potentially saving lives. The system uses inexpensive sensors to detect the type of accident and provides crucial information for response specialists.

SourceInderscience Publishers·JournalInternational Journal of Intelligent Defence Support Systems·DateFeb 9, 2009

Long-term use of popular inhalers increases risk of pneumonia for COPD patients

New research finds that long-term use of inhaled corticosteroid drugs increases the risk of pneumonia in patients with Chronic Obstructive Pulmonary Disease (COPD). Analysis of 18 randomized clinical trials showed a significant association between corticosteroid inhaler use and pneumonia, with nearly one in every 47 patients developing...

SourceAtrium Health Wake Forest Baptist·JournalArchives of Internal Medicine·DateFeb 9, 2009

Ongoing statin therapy associated with lower risk of death

Continuing statin therapy is associated with a reduced risk of death over four to five years, even among those without diagnosed heart disease. Patients who took statins for at least 90% of the follow-up period showed a 45% lower risk of death compared to those who did not adhere to treatment.

SourceJAMA Network·JournalArchives of Internal Medicine·DateFeb 9, 2009

MIT: Multiple genes implicated in autism

Researchers at MIT's Picower Institute for Learning and Memory found that two genes cause autism-like symptoms in mice, suggesting multiple genetic risk factors influence autistic symptoms' severity. The study may lead to drugs targeting signaling mechanisms between the two genes and a diagnostic target or biomarker.

SourceMassachusetts Institute of Technology·JournalProceedings of the National Academy of Sciences·DateFeb 9, 2009

Chronic low-back pain on the rise: UNC study finds 'alarming increase' in prevalence

A new UNC study finds that chronic low-back pain has more than doubled in North Carolina since the early 1990s, with a significant increase in prevalence across all ages and racial groups. The study suggests that increased healthcare costs for back problems may be due to rising prevalence rather than increased service use.

SourceUniversity of North Carolina Health Care·JournalArchives of Internal Medicine·DateFeb 9, 2009

Bar workers who smoke also benefit from smoking ban

Research found that bar workers' symptoms improved after a smoking ban in Scotland, with significant reductions in respiratory and sensory symptoms. The study also showed benefits for smokers themselves, highlighting the importance of addressing environmental tobacco smoke exposure at home.

SourceBMJ Group·JournalOccupational and Environmental Medicine·DateFeb 9, 2009

JCI online early table of contents: Feb. 9, 2009

Research suggests mice without AT1A protein have a significantly prolonged lifespan. This is attributed to reduced cellular oxidation, contributing to aging. Additionally, studies investigate the role of MT1-MMP in regulating hematopoietic progenitor cells' release from bone marrow.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateFeb 9, 2009

Novel economical blood test for hepatitis C

A novel blood test for hepatitis C virus has been developed by researchers at Bonn University and the Bernhard-Nocht Institute for Tropical Medicine. The test is significantly cheaper than existing commercial tests, while maintaining equal sensitivity, and can be used to monitor blood banks in poorer countries.

SourceUniversity of Bonn·JournalPLOS Medicine·DateFeb 9, 2009

The Hsp90-Antifungal Combo, please: Compromising fungi in the immunocompromised

Researchers at Whitehead Institute found that combining an antifungal agent with Hsp90 inhibition is effective against multiple types of resistant fungal infections. The treatment could lead to development of novel therapies for patients with compromised immune systems, who suffer high mortality rates from these infections.

SourceWhitehead Institute for Biomedical Research·JournalProceedings of the National Academy of Sciences·DateFeb 9, 2009

Biologists find gene network that gave rise to first tooth

Researchers have found a common genetic circuit controlling the formation of teeth in both jaws and throats of vertebrates. This discovery suggests that a core set of genes governs tooth development, regardless of location, and may also be involved in other patterned structures like hair and feathers.

SourcePLOS·JournalPLOS Biology·DateFeb 9, 2009

Autism Consortium members publish in PNAS: Mechanism, treatment for Rett syndrome -- top cause autism girls

The Autism Consortium has published a groundbreaking study defining the mechanism behind Rett syndrome, a neurodevelopmental disorder primarily affecting girls and a leading cause of autism. The research discovered that targeting the IGF1 signaling axis could be a promising therapeutic strategy for treating or reversing Rett Syndrome.

SourceAutism Consortium·JournalProceedings of the National Academy of Sciences·DateFeb 9, 2009

Study suggests possible treatment for neurological disorder Rett syndrome

Scientists at Whitehead Institute and MIT's Picower Institute have successfully treated a mouse model of Rett syndrome with daily injections of an active fragment of IGF-1, significantly reducing movement and respiratory irregularities. The treatment promotes nerve cell maturation and increases brain levels of IGF-1.

SourceWhitehead Institute for Biomedical Research·JournalProceedings of the National Academy of Sciences·DateFeb 9, 2009

A Zen discovery: Unrusted iron in ocean

A team of scientists has made a groundbreaking discovery that challenges the long-held assumption about oceanic iron cycles. They found that organic compounds can capture some iron spewed by hydrothermal vents, enabling it to be carried away in seawater and reaching the surface, where it can nourish marine life more efficiently.

SourceUniversity of Southern California·JournalNature Geoscience·DateFeb 8, 2009